Skandinaviska Enskilda Banken Ab (Publ) Enochian Biosciences Inc Transaction History

Skandinaviska Enskilda Banken Ab (Publ)

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 10, 2022	SELL	$1.93 - $8.73 $4,342 - $19,642	-2,250 Closed	0 $0
Q2 2020 Aug 13, 2020	SELL	$2.78 - $6.06 $15,150 - $33,027	-5,450 Reduced 70.78%	2,250 $9,000
Q1 2020 Jun 05, 2020	BUY	$2.08 - $5.41 $16,016 - $41,657	7,700 New	7,700 $23,000
Q1 2020 May 13, 2020	SELL	$2.08 - $5.41 $8,320 - $21,640	-4,000 Closed	0 $0
Q4 2019 Feb 14, 2020	BUY	$3.48 - $6.75 $3,480 - $6,750	1,000 Added 33.33%	4,000 $20,000
Q3 2019 Nov 08, 2019	BUY	$3.95 - $5.72 $11,850 - $17,160	3,000 New	3,000 $17,000

14.7M

24K

19.1K

Ticker ENOB
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 52,950,000
Market Cap $244M
Description
Enochian Biosciences, Inc., a pre-clinical stage biotechnology company, engages in the research and development of pharmaceutical and biological products for the human treatment of human immunodeficiency virus (HIV), hepatitis B virus (HBV), influenza and coronavirus infections, and cancer. The company's lead candidate includes ENOB-HV-01 for au...

Get notified when there are updates to the investment portfolio of Skandinaviska Enskilda Banken Ab (Publ), based on Form 13F filings with the SEC.

Stay updated on Skandinaviska Enskilda Banken Ab (Publ) with notifications on news.